Pineno Levin & Ford Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $9.96M | Buy |
168,675
+1,370
| +0.8% | +$67.9K | 2.93% | 8 |
|
|
2021
Q3 | $7.2M | Sell |
167,305
-1,128
| -0.7% | -$50K | 2.33% | 11 |
|
|
2021
Q2 | $6.6M | Sell |
168,433
-2,393
| -1% | -$93.1K | 2.13% | 14 |
|
|
2021
Q1 | $6.19M | Buy |
170,826
+1,525
| +0.9% | +$54.1K | 2.1% | 16 |
|
|
2020
Q4 | $6.23M | Sell |
169,301
-8,684
| -5% | -$319K | 2.23% | 14 |
|
|
2020
Q3 | $6.2M | Buy |
177,985
+726
| +0.4% | +$25.5K | 2.51% | 13 |
|
|
2020
Q2 | $5.5M | Buy |
177,259
+10,035
| +6% | +$341K | 2.4% | 16 |
|
|
2020
Q1 | $5.18M | Buy |
167,224
+13,393
| +9% | +$456K | 2.57% | 15 |
|
|
2019
Q4 | $5.72M | Sell |
153,831
-987
| -0.6% | -$35.2K | 2.17% | 17 |
|
|
2019
Q3 | $5.28M | Buy |
154,818
+211
| +0.1% | +$7.67K | 2.09% | 19 |
|
|
2019
Q2 | $6.35M | Sell |
154,607
-174
| -0.1% | -$6.91K | 2.5% | 12 |
|
|
2019
Q1 | $6.24M | Buy |
154,781
+1,969
| +1% | +$78.9K | 2.6% | 11 |
|
|
2018
Q4 | $6.33M | Sell |
152,812
-1,470
| -1% | -$61K | 2.88% | 5 |
|
|
2018
Q3 | $6.45M | Sell |
154,282
-185
| -0.1% | -$7.12K | 2.6% | 8 |
|
|
2018
Q2 | $5.32M | Sell |
154,467
-1,430
| -0.9% | -$48.9K | 2.32% | 15 |
|
|
2018
Q1 | $5.25M | Sell |
155,897
-3,196
| -2% | -$110K | 2.29% | 14 |
|
|
2017
Q4 | $5.47M | Buy |
159,093
+1,075
| +0.7% | +$36.7K | 2.28% | 13 |
|
|
2017
Q3 | $5.35M | Sell |
158,018
-4,584
| -3% | -$147K | 2.46% | 11 |
|
|
2017
Q2 | $5.18M | Sell |
162,602
-1,666
| -1% | -$52.5K | 2.45% | 11 |
|
|
2017
Q1 | $5.33M | Sell |
164,268
-108
| -0.1% | -$3.4K | 2.53% | 10 |
|
|
2016
Q4 | $5.07M | Buy |
164,376
+949
| +0.6% | +$29K | 2.44% | 10 |
|
|
2016
Q3 | $5.25M | Buy |
163,427
+4,549
| +3% | +$152K | 2.64% | 9 |
|
|
2016
Q2 | $5.31M | Sell |
158,878
-790
| -0.5% | -$25.2K | 2.75% | 7 |
|
|
2016
Q1 | $4.49M | Buy |
159,668
+1,237
| +0.8% | +$35.3K | 2.39% | 12 |
|
|
2015
Q4 | $4.85M | Sell |
158,431
-822
| -0.5% | -$25.9K | 2.59% | 8 |
|
|
2015
Q3 | $4.75M | Buy |
159,253
+663
| +0.4% | +$21.3K | 2.68% | 8 |
|
|
2015
Q2 | $5.04M | Buy |
158,590
+980
| +0.6% | +$31.9K | 2.61% | 7 |
|
|
2015
Q1 | $5.2M | Buy |
157,610
+949
| +0.6% | +$30.2K | 2.71% | 5 |
|
|
2014
Q4 | $4.63M | Sell |
156,661
-12,101
| -7% | -$347K | 2.73% | 6 |
|
|
2014
Q3 | $4.74M | Buy |
168,762
+1,506
| +0.9% | +$42.3K | 2.72% | 6 |
|
|
2014
Q2 | $4.71M | Buy |
167,256
+2,948
| +2% | +$84K | 2.64% | 6 |
|
|
2014
Q1 | $5.01M | Sell |
164,308
-2,570
| -2% | -$76.6K | 3.02% | 5 |
|
|
2013
Q4 | $4.85M | Buy |
166,878
+2,088
| +1% | +$60.8K | 2.94% | 5 |
|
|
2013
Q3 | $4.49M | Buy |
164,790
+1,334
| +0.8% | +$36.3K | 3.06% | 4 |
|
|
2013
Q2 | $4.34M | Buy |
+163,456
| New | +$4.52M | 3.1% | 5 |
|
Other funds holding PFE
Pineno Levin & Ford Asset Management's PFE Position: Q4 2021 in Review
Pineno Levin & Ford Asset Management increased its Pfizer (PFE) stake by 0.82% in Q4 2021, buying an estimated $67.9K and bringing the position to 168,675 shares worth $9.96M. The position accounts for 2.93% of the portfolio, ranked #8.
Pineno Levin & Ford Asset Management first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- Pineno Levin & Ford Asset Management held 168,675 shares of Pfizer worth $9.96M as of Q4 2021.
- Pineno Levin & Ford Asset Management bought 1,370 Pfizer shares in Q4 2021, an estimated $67.9K.
- Pfizer made up 2.93% of Pineno Levin & Ford Asset Management's portfolio in Q4 2021, its #8 holding.
- Pineno Levin & Ford Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on Pineno Levin & Ford Asset Management's 13F filing for Q4 2021, filed 21 Jan 2022.